Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Peripheral nerve stimulation & intrathecal pumps · New York | Peripheral nerve stimulation & intrathecal pumps · Pennsylvania | |
|---|---|---|
| Surgeons, 2024 | 22 | 15 |
| Medicare fee-for-service cases | 1,267 | 1,231 |
| Growth since 2019 (Medicare FFS) | +7.6%/yr | +6.1%/yr |
| Forecast cases (Medicare FFS) | 2,170 in 2030 | 1,540 in 2030 |
| Forecast growth | +9.4%/yr to 2030 | +3.8%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 0.6 | 0.8 |
| Medicare Advantage share | 57% | 58% |
| Out of hospital | 39% (+32 pts since 2019) | 44% (+28 pts since 2019) |
| Cases per surgeon | 58 | 82 |
| Top 10 surgeons' share | 65% | 82% |
| Surgeons growing | 0 | 0 |
| New since the base year | 8 | 4 |
| Likely to stop billing it | 6 by 2026 | 7 by 2026 |
| Forecast miss, 1 year (procedure) | 11% | 11% |
| Company payments per surgeon | $39K | $16K |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.